{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:48:22Z","timestamp":1775911702505,"version":"3.50.1"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P36259"],"award-info":[{"award-number":["P36259"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.critrevonc.2026.105265","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T15:44:16Z","timestamp":1772984656000},"page":"105265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel insights into UDP-glucuronosyltransferase 1A1 dysfunction and Gilbert\u2019s syndrome on estrogen metabolism and breast cancer"],"prefix":"10.1016","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9605-7989","authenticated-orcid":false,"given":"Sitara","family":"Shameem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Avery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Monti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene F.","family":"du Toit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Wegiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Heinz","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew Cameron","family":"Bulmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/B:BREA.0000025419.26423.b8","article-title":"Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer","volume":"85","author":"Adegoke","year":"2004","journal-title":"Breast Cancer Res Treat."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105265_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10101536","article-title":"Bilirubin as a therapeutic molecule: challenges and opportunities","volume":"10","author":"Adin","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.critrevonc.2026.105265_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.mgene.2020.100788","article-title":"Effect of gilbert's syndrome associated polymorphic alleles (rs8175347 and rs4148323) of UDP-glucuronyl transferase on serum bilirubin level","volume":"26","author":"Aliarab","year":"2020","journal-title":"Meta Gene"},{"issue":"122","key":"10.1016\/j.critrevonc.2026.105265_bib4","article-title":"Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression","volume":"9","author":"Allain","year":"2020","journal-title":"British J. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105265_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20224","article-title":"Estrogens and the risk of breast cancer: A narrative review of literature","volume":"9","author":"Al-Shami","year":"2023","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105265_bib6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1200\/JCO.19.01203","article-title":"Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221)","volume":"38","author":"Ambrosone","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105265_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-021-06354-w","article-title":"Investigating the role of endogenous estrogens, hormone replacement therapy, and blockade of estrogen receptor-\u03b1 activity on breast metabolic signaling","volume":"190","author":"Arnone","year":"2021","journal-title":"Breast Cancer Res Treat."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105265_bib8","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1248\/bpb.b17-00089","article-title":"Characterization of \u03b2-Estradiol 3-Glucuronidation in Rat Brain","volume":"40","author":"Asai","year":"2017","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105265_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mehy.2011.03.047","article-title":"Is Gilbert Syndrome a new risk factor for breast cancer","volume":"77","author":"Astolfi","year":"2011","journal-title":"Med. Hypotheses"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105265_bib10","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1742-4658.2007.05670.x","article-title":"Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7: Identification of a critical aromatic amino acid residue at position 33","volume":"274","author":"Barre","year":"2007","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0277-5379(90)90222-F","article-title":"Levels of eighteen non-conjugated and conjugated steroids in human breast cyst fluid: relationships with cyst type","volume":"26","author":"B\u00e9langer","year":"1990","journal-title":"Eur. J. Cancer"},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105265_bib12","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1073\/pnas.95.14.8170","article-title":"Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism","volume":"95","author":"Beutler","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105265_bib13","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1042\/bj0650774","article-title":"The excretion of bilirubin as a diglucuronide giving the direct van den Bergh reaction","volume":"65","author":"Billing","year":"1957","journal-title":"Biochem. J."},{"issue":"8970","key":"10.1016\/j.critrevonc.2026.105265_bib14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(95)92203-2","article-title":"Genetic inheritance of Gilbert\u2019s syndrome","volume":"346","author":"Bosma","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105265_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-8278(02)00359-8","article-title":"Inherited disorders of bilirubin metabolism","volume":"38","author":"Bosma","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.critrevonc.2026.105265_bib16","article-title":"Circulating Estrogen Metabolites and Risk of Breast Cancer among Postmenopausal Women in the Nurses\u2019 Health Study","author":"Brantley","year":"2024","journal-title":"Cancer Epidemiology Biomarkers & Prevention A Publication American Association Cancer Research Cosponsored American Society Preventive Oncology"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib17","doi-asserted-by":"crossref","first-page":"H429","DOI":"10.1152\/ajpheart.00417.2017","article-title":"Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea","volume":"315","author":"Bulmer","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105265_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41525-021-00208-6","article-title":"A UGT1A1 variant is associated with serum total bilirubin levels, which are causal for hypertension in African-ancestry individuals","volume":"6","author":"Chen","year":"2021","journal-title":"NPJ Genom. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ijc.20630","article-title":"Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility","volume":"113","author":"Cheng","year":"2005","journal-title":"Int J. Cancer"},{"issue":"31","key":"10.1016\/j.critrevonc.2026.105265_bib20","doi-asserted-by":"crossref","first-page":"10119","DOI":"10.1021\/bi960584a","article-title":"Evidence for overlapping active sites for 17 alpha-ethynlestradiol and bilirubin in the human major bilirubin UDPglucuronosyltransferase","volume":"35","author":"Ciotti","year":"1996","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105265_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076834","article-title":"A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer","volume":"24","author":"Clusan","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105265_bib22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/pr.58.4.8","article-title":"International Union of Pharmacology. LXIV. Estrogen receptors","volume":"58","author":"Dahlman-Wright","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105265_bib23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3109\/00498254.2012.663515","article-title":"Understanding Substrate Selectivity of Human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes","volume":"42","author":"Dong","year":"2012","journal-title":"Xenobiotica Fate Foreign Compd. Biol. Syst."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib24","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1158\/0008-5472.CAN-03-3295","article-title":"The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk","volume":"64","author":"Duguay","year":"2004","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105265_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/bj0570275","article-title":"Uridine compounds in glucuronic acid metabolism. I. The formation of glucuronides in liver suspensions","volume":"57","author":"Dutton","year":"1954","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105265_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0026-895X(25)13456-1","article-title":"Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol","volume":"43","author":"Ebner","year":"1993","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105265_bib27","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.1994.03520120057031","article-title":"Racial differences in survival from breast cancer. Results of the National Cancer Institute Black\/White Cancer Survival Study","volume":"272","author":"Eley","year":"1994","journal-title":"Jama"},{"issue":"49","key":"10.1016\/j.critrevonc.2026.105265_bib28","doi-asserted-by":"crossref","first-page":"18586","DOI":"10.1074\/jbc.RA119.010950","article-title":"Gut microbial \u03b2-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens","volume":"294","author":"Ervin","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2026.105265_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.apcsb.2019.01.001","article-title":"Estrogen receptor signaling mechanisms","volume":"116","author":"Fuentes","year":"2019","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105265_bib30","first-page":"923","article-title":"Prevalence of topoisomerase I genetic mutations and UGT1A1 polymorphisms associated with irinotecan in individuals of Asian descent","volume":"2","author":"Fukui","year":"2011","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105265_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70462","article-title":"Pre-Therapeutic UGT1A1 Genotyping in Breast Cancer Patients Receiving Sacituzumab Govitecan to Improve Safety: A Meta-Analysis and Recommendation","volume":"19","author":"Goedhart","year":"2026","journal-title":"Clin. Transl. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105265_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/bcr936","article-title":"Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview","volume":"6","author":"Guillemette","year":"2004","journal-title":"Breast Cancer Res"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105265_bib33","first-page":"711","article-title":"Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels","volume":"10","author":"Guillemette","year":"2001","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/clpt.2014.126","article-title":"Pharmacogenomics of human uridine diphospho-glucuronosyltransferases and clinical implications","volume":"96","author":"Guillemette","year":"2014","journal-title":"Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105265_bib35","first-page":"950","article-title":"Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans","volume":"60","author":"Guillemette","year":"2000","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tem.2018.01.002","article-title":"Bilirubin in the Liver\u2013Gut Signaling Axis","volume":"29","author":"Hamoud","year":"2018","journal-title":"Trends Endocrinol. & Metab."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105265_bib37","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00280-014-2405-0","article-title":"Associations between UGT1A1*6 or UGT1A1*6\/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients","volume":"73","author":"Han","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib38","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1152\/physrev.00004.2019","article-title":"Molecular Physiology and Pathophysiology of Bilirubin Handling by the Blood, Liver, Intestine, and Brain in the Newborn","volume":"100","author":"Hansen","year":"2020","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib39","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00026.2006","article-title":"Estrogen receptors: how do they signal and what are their targets","volume":"87","author":"Heldring","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.critrevonc.2026.105265_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108773","article-title":"Glucuronidation of orally administered drugs and the value of nanocarriers in strategies for its overcome","volume":"266","author":"Hervieu","year":"2025","journal-title":"Pharmacol. & Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105265_bib41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10147-013-0558-1","article-title":"Usefulness of one-point plasma SN-38G\/SN-38 concentration ratios as a substitute for UGT1A1 genetic information after irinotecan administration","volume":"19","author":"Hirose","year":"2014","journal-title":"Int J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/1055-9965.EPI-06-0831","article-title":"Ovarian cancer risk and polymorphisms involved in estrogen catabolism","volume":"16","author":"Holt","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105265_bib43","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/dmd.106.014183","article-title":"UDP-Glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women","volume":"35","author":"Hong","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105265_bib44","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/thoraxjnl-2020-214756","article-title":"Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank","volume":"75","author":"Horsfall","year":"2020","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105265_bib45","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/1097-0142(19920501)69:9<2349::AID-CNCR2820690925>3.0.CO;2-7","article-title":"A collaborative study of differences in the survival rates of black patients and white patients with cancer","volume":"69","author":"Howard","year":"1992","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105265_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174491","article-title":"The Expression Profiles and Deregulation of UDP-Glycosyltransferase (UGT) Genes in Human Cancers and Their Association with Clinical Outcomes","volume":"13","author":"Hu","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105265_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10549-007-9720-7","article-title":"Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans","volume":"110","author":"Huo","year":"2008","journal-title":"Breast Cancer Res Treat."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105265_bib48","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/jnci\/djae172","article-title":"Risk factors for breast cancer subtypes by race and ethnicity: a scoping review","volume":"116","author":"Hurson","year":"2024","journal-title":"JNCI Journal National Cancer Institute"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105265_bib49","doi-asserted-by":"crossref","first-page":"13224","DOI":"10.1038\/s41598-021-92442-2","article-title":"Association of serum bilirubin levels with risk of cancer development and total death","volume":"11","author":"Inoguchi","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105265_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11060554","article-title":"The Functionality of UDP-Glucuronosyltransferase Genetic Variants and their Association with Drug Responses and Human Diseases","volume":"11","author":"Jarrar","year":"2021","journal-title":"J. Pers. Med"},{"key":"10.1016\/j.critrevonc.2026.105265_bib51","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.15_suppl.4503","article-title":"Genome-wide association study (GWAS) of efficacy and safety endpoints in pazopanib- or sunitinib-treated patients with renal cell carcinoma (RCC)","author":"Johnson","year":"2014","journal-title":"J. Clin. Oncol. 32(15_suppl) 45034503"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.canep.2010.02.009","article-title":"Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men","volume":"34","author":"Karatzas","year":"2010","journal-title":"Cancer Epidemiol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105265_bib53","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s004310000603","article-title":"Gilbert syndrome: analysis of the promoter region of the uridine diphosphate-glucuronosyltransferase 1 gene in the Greek population","volume":"159","author":"Kavazarakis","year":"2000","journal-title":"Eur. J. Pedia"},{"key":"10.1016\/j.critrevonc.2026.105265_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.655320","article-title":"Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes","volume":"12","author":"Khatri","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105265_bib55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.annonc.2024.10.824","article-title":"Estrogens and breast cancer","volume":"36","author":"Kim","year":"2025","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105265_bib56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/abbi.1996.0320","article-title":"The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1","volume":"332","author":"King","year":"1996","journal-title":"Arch. Biochem Biophys."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105265_bib57","article-title":"The Intestinal Microbiome and Estrogen Receptor\u2013Positive Female Breast Cancer","volume":"108","author":"Kwa","year":"2016","journal-title":"JNCI Journal National Cancer Institute"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105265_bib58","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2008.12.030","article-title":"Gilbert\u2019s syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment","volume":"50","author":"Lankisch","year":"2009","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib59","first-page":"137","article-title":"Characteristics and Clinical Implication of UGT1A1 Heterozygous Mutation in Tumor","volume":"25","author":"Li","year":"2022","journal-title":"Zhongguo Fei Ai Za Zhi = Chin. J. Lung Cancer"},{"key":"10.1016\/j.critrevonc.2026.105265_bib60","article-title":"miR-452 Reverses Abnormal Glycosylation Modification of ER\u03b1 and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105265_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2021.2001493","article-title":"The relationship between UGT1A1 gene & various diseases and prevention strategies","volume":"54","author":"Liu","year":"2022","journal-title":"Drug Metab. Rev."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1742-7843.2007.00112.x","article-title":"Substrate-dependent modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) by propofol in recombinant human UGT1A1 and human liver microsomes","volume":"101","author":"Mano","year":"2007","journal-title":"Basic Clin. Pharm. Toxicol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105265_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40001-018-0328-7","article-title":"Membrane-bound estrogen receptor alpha initiated signaling is dynamin dependent in breast cancer cells","volume":"23","author":"Marczell","year":"2018","journal-title":"Eur. J. Med. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105265_bib64","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/physrev.00058.2017","article-title":"The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms","volume":"99","author":"Meech","year":"2019","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib65","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/pr.2015.247","article-title":"Inherited disorders of bilirubin clearance","volume":"79","author":"Memon","year":"2016","journal-title":"Pedia Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105265_bib66","first-page":"179","article-title":"Sclera Segmentation in Images for Bilirubin Level Measurement Using the U-Net Network","volume":"9","author":"Mendoza-Mora","year":"2024","journal-title":"Av. En. Inter. \u00f3N. Hum. Comput."},{"key":"10.1016\/j.critrevonc.2026.105265_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.05.047","article-title":"Determination of the age of bruises using a bilirubinometer","volume":"302","author":"Mesli","year":"2019","journal-title":"Forensic Sci. Int."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105265_bib68","first-page":"4992","article-title":"4-Hydroxy estrogen metabolite, causing genomic instability by attenuating the function of spindle-assembly checkpoint, can serve as a biomarker for breast cancer","volume":"11","author":"Miao","year":"2019","journal-title":"Am. J. Transl. Res"},{"key":"10.1016\/j.critrevonc.2026.105265_bib69","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0300-483X(02)00449-3","article-title":"Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance","volume":"181\u2013182","author":"Miners","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.critrevonc.2026.105265_bib70","first-page":"248","article-title":"Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance","author":"Miners","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105265_bib71","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14756366.2021.2020773","article-title":"Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin","volume":"37","author":"Nocentini","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105265_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118032","article-title":"Bilirubin in metabolic syndrome and associated inflammatory diseases: New perspectives","volume":"257","author":"Nov\u00e1k","year":"2020","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105265_bib73","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3390\/cancers14092265","article-title":"Estrogens, Cancer and Immunity","volume":"14","author":"Orzo\u0142ek","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105265_bib74","article-title":"Environmental endocrine disruptors: rethinking the origins of early-onset ER+ breast cancer","author":"Parrish","year":"2025","journal-title":"Nature Reviews Cancer 2025 2511 25(11) 819820"},{"key":"10.1016\/j.critrevonc.2026.105265_bib75","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.steroids.2014.06.012","article-title":"Estrogen Receptors Alpha (ER\u03b1) and Beta (ER\u03b2): Subtype-Selective Ligands and Clinical Potential","volume":"0","author":"Paterni","year":"2014","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105265_bib76","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/jn\/135.5.1051","article-title":"Cruciferae Interact with the UGT1A1*28 Polymorphism to Determine Serum Bilirubin Levels in Humans","volume":"135","author":"Peterson","year":"2005","journal-title":"J. Nutr."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105265_bib77","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.2174\/092986712802430072","article-title":"Synthetic 2-methoxyestradiol derivatives: structure-activity relationships","volume":"19","author":"Peyrat","year":"2012","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.critrevonc.2026.105265_bib78","first-page":"659","author":"Plewig","year":"2020","journal-title":"Estrogens Oral. Contracept. ACNE ROSACEA"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105265_bib79","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0021-9258(17)35280-8","article-title":"Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells","volume":"266","author":"Ritter","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105265_bib80","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tem.2017.11.005","article-title":"Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes","volume":"29","author":"Rochette","year":"2018","journal-title":"Trends Endocrinol. & Metab."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105265_bib81","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1086\/466531","article-title":"Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia","volume":"192","author":"Rotger","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib82","article-title":"Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders","volume":"11","author":"Ryter","year":"2022","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105265_bib83","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.15_suppl.5574","article-title":"Genome-wide association study (GWAS) of pazopanib efficacy and safety in patients with ovarian cancer who have not progressed following first-line standard therapy","author":"Scambia","year":"2014","journal-title":"J. Clin. Oncol. 32(15_suppl) 55745574"},{"issue":"3211","key":"10.1016\/j.critrevonc.2026.105265_bib84","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.124.3211.76","article-title":"Direct-reacting bilirubin, bilirubin glucuronide, in serum, bile and urine","volume":"124","author":"Schmid","year":"1956","journal-title":"Science (New York N. Y. )"},{"key":"10.1016\/j.critrevonc.2026.105265_bib85","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-1554-6_1","article-title":"Fundamentals of Enzyme Kinetics: Michaelis-Menten and Non-Michaelis-Type (Atypical) Enzyme Kinetics","volume":"2342","author":"Seibert","year":"2021","journal-title":"Methods Mol. Biol. (Clifton N. J. )"},{"key":"10.1016\/j.critrevonc.2026.105265_bib86","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj3030233","article-title":"Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation","volume":"303","author":"Senafi","year":"1994","journal-title":"Biochem J."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105265_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020394","article-title":"Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study","volume":"10","author":"Seyed Khoei","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105265_bib88","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01703-w","article-title":"Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses","volume":"18","author":"Seyed Khoei","year":"2020","journal-title":"BMC Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105265_bib89","doi-asserted-by":"crossref","first-page":"10421","DOI":"10.1007\/s11033-022-07757-8","article-title":"Molecular mechanisms of bilirubin induced G1 cell cycle arrest and apoptosis in human breast cancer cell lines: involvement of the intrinsic pathway","volume":"49","author":"Shahrokhi","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105265_bib90","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1134\/S0026893306020075","article-title":"[Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women]","volume":"40","author":"Shatalova","year":"2006","journal-title":"Mol. Biol. (Mosk. )"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105265_bib91","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/15230860260220094","article-title":"Heme degradation and human disease: diversity is the soul of life","volume":"4","author":"Shibahara","year":"2002","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.critrevonc.2026.105265_bib92","first-page":"e1","article-title":"Prevalence of the UGT1A1*28 promoter polymorphism and breast cancer risk among African American women in Memphis, TN","volume":"3","author":"Smith","year":"2019","journal-title":"Cancer Health Disparities"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105265_bib93","doi-asserted-by":"crossref","first-page":"R488","DOI":"10.1186\/bcr818","article-title":"UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients","volume":"6","author":"Sparks","year":"2004","journal-title":"Breast Cancer Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105265_bib94","article-title":"Characterization of UDP-glucuronosyltransferase (UGT1A1) Promoter Polymorphisms and Gene Expression on Ethnicity, Stage of Disease, and Menopausal Status in Breast Cancer","volume":"2012","author":"Starlard-Davenport","year":"2012","journal-title":"J. Drug Metab. Toxicol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib95","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer Journal Clinicians"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105265_bib96","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/jnci\/88.9.617","article-title":"Ethnic differences in estrogen metabolism in healthy women","volume":"88","author":"Taioli","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"issue":"4528","key":"10.1016\/j.critrevonc.2026.105265_bib97","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/178312a0","article-title":"Properties and composition of the bile pigment giving a direct diazo reaction","volume":"178","author":"Talafant","year":"1956","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031817","article-title":"Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer","volume":"25","author":"Tien","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105265_bib99","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/gte.2007.0020","article-title":"Genetic polymorphisms in the UGT1A1 gene and breast cancer risk in Greek women","volume":"11","author":"Tsezou","year":"2007","journal-title":"Genet Test."},{"key":"10.1016\/j.critrevonc.2026.105265_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.586715","article-title":"Mitochondrial Function, Fatty Acid Metabolism, and Body Composition in the Hyperbilirubinemic Gunn Rat","volume":"12","author":"Vidimce","year":"2021","journal-title":"Front Pharm."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105265_bib101","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jhep.2023.06.004","article-title":"Gilbert\u2019s syndrome revisited","volume":"79","author":"V\u00edtek","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.critrevonc.2026.105265_bib102","first-page":"1","article-title":"Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases","volume":"129","author":"Wagner","year":"2015"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105265_bib103","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10408363.2018.1428526","article-title":"Diagnostic criteria and contributors to Gilbert\u2019s syndrome","volume":"55","author":"Wagner","year":"2018","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105265_bib104","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1124\/dmd.30.12.1462","article-title":"Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10","volume":"30","author":"Watanabe","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105265_bib105","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1124\/dmd.30.11.1266","article-title":"Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes","volume":"30","author":"Williams","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.critrevonc.2026.105265_bib106","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpba.2013.08.024","article-title":"Absolute quantification of UGT1A1 in various tissues and cell lines using isotope label-free UPLC-MS\/MS method determines its turnover number and correlates with its glucuronidation activities","volume":"88","author":"Xu","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105265_bib107","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1124\/dmd.124.001640","article-title":"Activation of the YY1-UGT2B7 Axis Promotes Mammary Estrogen Homeostasis Dysregulation and Exacerbates Breast Tumor Metastasis","volume":"52","author":"Xu","year":"2024","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.critrevonc.2026.105265_bib108","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.phrs.2017.05.001","article-title":"UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: A systematic review of UGT isoforms for precision medicine","volume":"121","author":"Yang","year":"2017","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105265_bib109","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00011-025-02049-w","article-title":"Bilirubin metabolism and its application in disease prevention: mechanisms and research advances","volume":"74","author":"Zhang","year":"2025","journal-title":"Inflamm. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105265_bib110","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/dmd.110.035030","article-title":"Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates\/inhibitors","volume":"39","author":"Zhou","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105265_bib111","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.xphs.2017.04.073","article-title":"Disturbance of mammary UDP-glucuronosyltransferase represses estrogen metabolism and exacerbates experimental breast cancer","volume":"106","author":"Zhou","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.critrevonc.2026.105265_bib112","first-page":"11","article-title":"Gilbert\u2019s syndrome and the gut microbiota - insights from the case-control BILIHEALTH study","author":"Z\u00f6hrer","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T11:52:02Z","timestamp":1775908322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":112,"alternative-id":["S1040842826001526"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105265","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel insights into UDP-glucuronosyltransferase 1A1 dysfunction and Gilbert\u2019s syndrome on estrogen metabolism and breast cancer","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105265"}}